Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
Condition(s):Chorea, HuntingtonLast Updated:March 15, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Chorea, HuntingtonLast Updated:March 15, 2024Enrolling by invitation
Condition(s):Major Depressive DisorderLast Updated:March 25, 2024Recruiting
Condition(s):Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Major Depressive Disorder; Tardive DyskinesiaLast Updated:March 12, 2024Recruiting
Condition(s):SchizophreniaLast Updated:December 15, 2023Terminated
Condition(s):SchizophreniaLast Updated:September 18, 2023Recruiting
Condition(s):Focal Onset Seizure; Focal Onset EpilepsyLast Updated:July 20, 2023Enrolling by invitation
Condition(s):Epileptic Encephalopathy; Continuous Spike and Wave During SleepLast Updated:August 21, 2023Enrolling by invitation
Condition(s):SCN8A Developmental and Epileptic Encephalopathy SyndromeLast Updated:November 2, 2023Enrolling by invitation
Condition(s):Dyskinesia; Cerebral PalsyLast Updated:March 12, 2024Recruiting
Condition(s):Major Depressive DisorderLast Updated:March 25, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.